InvestorsHub Logo
Followers 829
Posts 119605
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Friday, 12/01/2017 11:38:37 AM

Friday, December 01, 2017 11:38:37 AM

Post# of 294
FDA approves Ogivri (Herceptin FoB) from MYL/Biocon:

https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm587378.htm

Note: MYL has two global FoB partnerships: one with Biocon (#msg-39119393) and one with MNTA (#msg-119689602).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTRS News